Crucial role of IL1beta and C3a in the in vitro-response of multipotent mesenchymal stromal cells to inflammatory mediators of polytrauma

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Hengartner, Nina Emily ^a   Fiedler, Jörg ^a   Schrezenmeier, Hubert ^b   Huber Lang, Markus ^a   Brenner, Rolf E ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; TOLL LIKE RECEPTOR 3; AUTACOID; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; ISOMERASE; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; TNFAIP6 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; MESENCHYMAL STROMA CELL; MULTIPLE TRAUMA; PROTEIN ANALYSIS; PROTEIN FUNCTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; UPREGULATION; ZYMOGRAPHY; BONE MARROW CELL; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM;

BONE MARROW CELLS; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINES; COMPLEMENT C3A; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTRAMOLECULAR OXIDOREDUCTASES; MATRIX METALLOPROTEINASE 1; MESENCHYMAL STROMAL CELLS; UP-REGULATION;

EID: 84920815734     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116772     Document Type: Article

References (59)

1. Matthes G, Seifert J, Ostermann PA, Wurfel S, Ekkernkamp A, et al. (2001) Early death of the severly injured patient - A retrospective analysis. Zentralbl Chir 126: 995-999. doi: 10.1055/s-2001-19658 PMID: 11805900
2. Keel M, Trentz O (2005) Pathophysiology of polytrauma. Injury 36: 691-709. doi: 10.1016/j.injury.2004.12.037 PMID: 15910820
3. Kohl J (2006) The role of complement in danger sensing and transmission. Immunol Res 34: 157-176. doi: 10.1385/IR:34:2:157 PMID: 16760575
4. Hensler T, Heinemann B, Sauerland S, Lefering R, Bouillon B, et al. (2003) Immunologic alterations associated with high blood transfusion volume after multiple injury: effects on plasmatic cytokine and cytokine receptor concentrations. Shock 20: 497-502. doi: 10.1097/01.shk.0000095058.62263.1f PMID: 14625472
5. Giannoudis PV, Smith MR, Evans RT, Bellamy MC, Guillou PJ (1998) Serum CRP and IL-6 levels after trauma. Not predictive of septic complications in 31 patients. Acta orthopaedica Scandinavica 69: 184-188.
6. Maier B, Lefering R, Lehnert M, Laurer HL, Steudel WI, et al. (2007) Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma. Shock 28: 668-674. PMID: 18092384
7. Bogner V, Keil L, Kanz KG, Kirchhoff C, Leidel BA, et al. (2009) Very early posttraumatic serum alterations are significantly associated to initial massive RBC substitution, injury severity, multiple organ failure and adverse clinical outcome in multiple injured patients. European journal of medical research 14: 284-291. doi: 10.1186/2047-783X-14-7-284 PMID: 19661010
8. Zilow G, Sturm JA, Rother U, Kirschfink M (1990) Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clinical and experimental immunology 79: 151-157. doi: 10.1111/j.1365-2249.1990.tb05171.x PMID: 2311295
9. Hecke F, Schmidt U, Kola A, Bautsch W, Klos A, et al. (1997) Circulating complement proteins in multiple trauma patients - correlation with injury severity, development of sepsis, and outcome. Critical care medicine 25: 2015-2024. doi: 10.1097/00003246-199712000-00019 PMID: 9403752
10. Burk AM, Martin M, Flierl MA, Rittirsch D, Helm M, et al. (2012) Early complementopathy after multiple injuries in humans. Shock 37: 348-354. doi: 10.1097/SHK.0b013e3182471795 PMID: 22258234
11. Ganter MT, Brohi K, Cohen MJ, Shaffer LA, Walsh MC, et al. (2007) Role of the alternative pathway in the early complement activation following major trauma. Shock 28: 29-34. doi: 10.1097/shk.0b013e3180342439 PMID: 17510601
12. Roumen RM, Hendriks T, van der Ven-Jongekrijg J, Nieuwenhuijzen GA, Sauerwein RW, et al. (1993) Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Annals of surgery 218: 769-776.
13. Chiaretti A, Genovese O, Aloe L, Antonelli A, Piastra M, et al. (2005) Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst 21: 185-193; discussion 194. doi: 10.1007/s00381-004-1032-1 PMID: 15455248
14. Ramírez M, Lucia A, Gómez-Gallego F, Esteve-Lanao J, Pérez-Martínez A, et al. (2006) Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury. Br J Sports Med 40: 719-722. doi: 10.1136/bjsm.2006.028639 PMID: 16807304
15. Rochefort GY, Delorme B, Lopez A, Herault O, Bonnet P, et al. (2006) Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 24: 2202-2208. doi: 10.1634/stemcells.2006-0164 PMID: 16778152
16. Alm JJ, Koivu HMA, Heino TJ, Hentunen TA, Laitinen S, et al. (2010) Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. J Orthop Res 28: 1634-1642. doi: 10.1002/jor.21167 PMID: 20540091
17. Lucia A, De La Rosa A, Silván MA, López-Mojares LM, Boraita A, et al. (2009) Mobilisation of mesenchymal cells in cardiac patients: is intense exercise necessary? Br J Sports Med 43: 221-223. doi: 10.1136/bjsm.2007.044693 PMID: 18400877
18. Williams JT, Southerland SS, Souza J, Calcutt AF, Cartledge RG (1999) Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 65: 22-26. PMID: 9915526
19. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228. doi: 10.1089/107632701300062859 PMID: 11304456
20. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44: 1928-1942. doi: 10.1002/1529-0131(200108) 44:8%3C1928::AID-ART331%3E3.0.CO;2-P PMID: 11508446
21. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S (2000) Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A 97: 13625-13630. doi: 10.1073/pnas.240309797 PMID: 11087820
22. da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213. doi: 10.1242/jcs.02932 PMID: 16684817
23. Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, et al. (2005) Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112: 1451-1461. doi: 10.1161/CIRCULATIONAHA.105.537480 PMID: 16129797
24. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, et al. (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5: 54-63. doi: 10.1016/j.stem.2009.05.003 PMID: 19570514
25. Yukawa H, Watanabe M, Kaji N, Okamoto Y, Tokeshi M, et al. (2012) Monitoring transplanted adipose tissue-derived stem cells combined with heparin in the liver by fluorescence imaging using quantum dots. Biomaterials 33: 2177-2186. doi: 10.1016/j.biomaterials.2011.12.009 PMID: 22192539
26. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI (2001) The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169: 12-20. doi: 10.1159/000047856 PMID: 11340257
27. Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, et al. (2010) Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 19: 667-679. doi: 10.3727/096368910X508762 PMID: 20525442
28. Carrero R, Cerrada I, Lledo E, Dopazo J, Garcia-Garcia F, et al. (2012) IL1beta induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-kappaB. Stem Cell Rev 8: 905-916. doi: 10.1007/s12015-012-9364-9 PMID: 22467443
29. Tu Z, Li Q, Bu H, Lin F (2010) Mesenchymal stem cells inhibit complement activation by secreting factor H. Stem Cells Dev 19: 1803-1809. doi: 10.1089/scd.2009.0418 PMID: 20163251
30. Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Pescatori M, et al. (2010) Inflammatory conditions affect gene expression and function of human adipose tissue-derivedmesenchymal stem cells. Clinical and experimental immunology 162: 474-486. doi: 10.1111/j.1365-2249.2010.04256.x PMID: 20846162
31. Németh K, Leelahavanichkul A, Yuen PST, Mayer B, Parmelee A, et al. (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49. doi: 10.1038/nm.1905 PMID: 19098906
32. Joos H, Wildner A, Hogrefe C, Reichel H, Brenner RE (2013) Interleukin-1 beta and tumor necrosis factor alpha inhibit migration activity of chondrogenic progenitor cells from non-fibrillated osteoarthritic cartilage. Arthritis Res Ther 15: R119.
33. Fickert S, Fiedler J, Brenner RE (2004) Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers. Arthritis Res Ther 6: R422-432.
34. Fiedler J, Brill C, Blum WF, Brenner RE (2006) IGF-I and IGF-II stimulate directed cell migration of bone-marrow-derived human mesenchymal progenitor cells. Biochem Biophys Res Commun 345: 1177-1183. doi: 10.1016/j.bbrc.2006.05.034 PMID: 16716263
35. Fiedler J, Etzel N, Brenner RE (2004) To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem 93: 990-998. doi: 10.1002/jcb.20219 PMID: 15389881
36. Fiedler J, Leucht F, Waltenberger J, Dehio C, Brenner RE (2005) VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 334: 561-568. doi: 10.1016/j.bbrc.2005.06.116 PMID: 16005848
37. Devine MJ, Mierisch CM, Jang E, Anderson PC, Balian G (2002) Transplanted bone marrow cells localize to fracture callus in a mouse model. J Orthop Res 20: 1232-1239. doi: 10.1016/S0736-0266(02) 00051-7 PMID: 12472234
38. Francois S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, et al. (2006) Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 24: 1020-1029. doi: 10.1634/stemcells.2005-0260 PMID: 16339642
39. Ames RS, Lee D, Foley JJ, Jurewicz AJ, Tornetta MA, et al. (2001) Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol 166: 6341-6348. doi: 10.4049/jimmunol.166.10.6341 PMID: 11342658
40. Schraufstatter IU, Discipio RG, Zhao M, Khaldoyanidi SK (2009) C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. J Immunol 182: 3827-3836. doi: 10.4049/jimmunol.0803055 PMID: 19265162
41. Hengartner NE, Fiedler J, Ignatius A, Brenner RE (2013) IL-1beta Inhibits Human Osteoblast Migration. Molecular medicine 19: 36-42. doi: 10.2119/molmed.2012.00058 PMID: 23508571
42. Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D (2010) Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res 316: 3417-3424. doi: 10.1016/j.yexcr.2010.07.002 PMID: 20633553
43. Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, et al. (2006) Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24: 1750-1758. doi: 10.1634/stemcells.2005-0191 PMID: 16822883
44. Mishima Y, Lotz M (2008) Chemotaxis of human articular chondrocytes and mesenchymal stem cells. J Orthop Res 26: 1407-1412. doi: 10.1002/jor.20668 PMID: 18464249
45. Ignatius A, Ehrnthaller C, Brenner RE, Kreja L, Schoengraf P, et al. (2011) The anaphylatoxin receptor C5aR is present during fracture healing in rats and mediates osteoblast migration in vitro. J Trauma 71: 952-960. doi: 10.1097/TA.0b013e3181f8aa2d PMID: 21460748
46. Ries C, Egea V, Karow M, Kolb H, Jochum M, et al. (2007) MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109: 4055-4063. doi: 10.1182/blood-2006-10-051060 PMID: 17197427
47. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92: 827-839. doi: 10.1161/01.RES.0000070112.80711.3D PMID: 12730128
48. Raffaghello L, Bianchi G, Bertolotto M, Montecucco F, Busca A, et al. (2008) Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 26: 151-162. doi: 10.1634/stemcells.2007-0416 PMID: 17932421
49. Zhang Q-Z, Su W-R, Shi S-H, Wilder-Smith P, Xiang AP, et al. (2010) Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28: 1856-1868. doi: 10.1002/stem.503 PMID: 20734355
50. Ylostalo JH, Bartosh TJ, Coble K, Prockop DJ (2012) Human mesenchymal stem/stromal cells cultured as spheroids are self-activated to produce prostaglandin E2 that directs stimulated macrophages into an anti-inflammatory phenotype. Stem Cells 30: 2283-2296. doi: 10.1002/stem.1191 PMID: 22865689
51. Foraker JE, Oh JY, Ylostalo JH, Lee RH, Watanabe J, et al. (2011) Cross-talk between human mesenchymal stem/progenitor cells (MSCs) and rat hippocampal slices in LPS-stimulated cocultures: the MSCs are activated to secrete prostaglandin E2. J Neurochem 119: 1052-1063. doi: 10.1111/j.1471-4159.2011.07511.x PMID: 21954847
52. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. Blood 118: 330-338. doi: 10.1182/blood-2010-12-327353 PMID: 21551236
53. Qi Y, Jiang D, Sindrilaru A, Stegemann A, Schatz S, et al. (2014) TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine fullthickness skin wounds. J Invest Dermatol 134: 526-537. doi: 10.1038/jid.2013.328 PMID: 23921952
54. Bartosh TJ, Ylostalo JH, Bazhanov N, Kuhlman J, Prockop DJ (2013) Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1). Stem Cells 31: 2443-2456. doi: 10.1002/stem.1499 PMID: 23922312
55. Krumina G, Babarykin D, Krumina Z, Paegle I, Suhorukov O, et al. (2013) Effects of systemically transplanted allogeneic bone marrow multipotent mesenchymal stromal cells on rats' recovery after experimental polytrauma. J Trauma Acute Care Surg 74: 785-791. doi: 10.1097/TA.0b013e31827e1879 PMID: 23425736
56. Weckbach S, Perl M, Heiland T, Braumuller S, Stahel PF, et al. (2012) A new experimental polytrauma model in rats: molecular characterization of the early inflammatory response. Mediators Inflamm 2012: 890816. doi: 10.1155/2012/890816 PMID: 22481866
57. Liang J, Zhang H, Hua B, Wang H, Lu L, et al. (2010) Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 69: 1423-1429. doi: 10.1136/ard.2009.123463 PMID: 20650877
58. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, et al. (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586. doi: 10.1016/S0140-6736(08)60690-X PMID: 18468541
59. Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, et al. (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6: 1282-1286. doi: 10.1038/81395 PMID: 11062543